Texas Attorney General Ken Paxton (Joel Martinez/The Monitor via AP Images, File)
November 21, 2023 02:28 PM EST
Pharma
Law

Texas at­tor­ney gen­er­al sues Pfiz­er, Tris Phar­ma over man­u­fac­tur­ing is­sues sur­round­ing AD­HD med

Nicole DeFeudis

Editor

Pfiz­er and Tris Phar­ma are at the cen­ter of a new law­suit al­leg­ing they hid man­u­fac­tur­ing prob­lems re­lat­ed to an AD­HD med­ica­tion and de­fraud­ed the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Re­cur­sion re­duces work­force; Ox­ford Nanopore teams up with UK Biobank

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times